share_log

ProKidney FY 2024 GAAP EPS $(0.62) Misses $(0.57) Estimate, Ended The Fourth Quarter With $358M In Cash And Cash Equivalents And Marketable Securities, Supporting Operations Into Mid-2027

Benzinga ·  Mar 17 11:32

ProKidney (NASDAQ:PROK) reported quarterly losses of $(0.62) per share which missed the analyst consensus estimate of $(0.57) by 8.77 percent. This is a 8.77 percent decrease over losses of $(0.57) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 294

Recommended

Write a comment